madman
Super Moderator
In his latest interview with iconic physicians in urology, uro-oncology, and related fields, GRU contributing editor Neil H. Baum, MD, interviews Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, on his clinical research and experience using testosterone to treat patients in a number of contexts. The two discuss Dr. Morgentaler’s groundbreaking research into the nuances of testosterone, men’s health, and prostate cancer, as well as how his Saturation Theory of testosterone has led to breakthroughs in quality-of-life improvements across a range of diseases.
